nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An overview of the Cure SMA membership database: Highlights of key demographic and clinical characteristics of SMA members
|
Belter, Lisa |
|
2018 |
5 |
2 |
p. 167-176 |
artikel |
2 |
A Qualitative Approach to Health Related Quality-of-Life in Congenital Muscular Dystrophy
|
Cornwall, Kylie M. |
|
2018 |
5 |
2 |
p. 251-255 |
artikel |
3 |
Beta-2 Adrenergic Receptor Agonists Enhance AChR Clustering in C2C12 Myotubes: Implications for Therapy of Myasthenic Disorders
|
Clausen, Lisa |
|
2018 |
5 |
2 |
p. 231-240 |
artikel |
4 |
Characteristics of Japanese Patients with Becker Muscular Dystrophy and Intermediate Muscular Dystrophy in a Japanese National Registry of Muscular Dystrophy (Remudy): Heterogeneity and Clinical Variation
|
Mori-Yoshimura, Madoka |
|
2018 |
5 |
2 |
p. 193-203 |
artikel |
5 |
Current Classification and Management of Inflammatory Myopathies
|
Schmidt, Jens |
|
2018 |
5 |
2 |
p. 109-129 |
artikel |
6 |
Determination of qPCR Reference Genes Suitable for Normalizing Gene Expression in a Canine Model of Duchenne Muscular Dystrophy
|
Hildyard, John C.W. |
|
2018 |
5 |
2 |
p. 177-191 |
artikel |
7 |
Efficacy of Rituximab in Refractory Generalized anti-AChR Myasthenia Gravis
|
Landon-Cardinal, Océane |
|
2018 |
5 |
2 |
p. 241-249 |
artikel |
8 |
Evaluation of Children with SMA Type 1 Under Treatment with Nusinersen within the Expanded Access Program in Germany
|
Pechmann, Astrid |
|
2018 |
5 |
2 |
p. 135-143 |
artikel |
9 |
Evaluator Training and Reliability for SMA Global Nusinersen Trials1
|
Glanzman, Allan M. |
|
2018 |
5 |
2 |
p. 159-166 |
artikel |
10 |
Novel SPEG Mutations in Congenital Myopathy without Centralized Nuclei
|
Lornage, Xavière |
|
2018 |
5 |
2 |
p. 257-260 |
artikel |
11 |
Participation and the Role of Neuropsychological Functioning in Myotonic Dystrophy Type 1
|
Van Heugten, Caroline |
|
2018 |
5 |
2 |
p. 205-214 |
artikel |
12 |
Position Statement: Sharing of Clinical Research Data in Spinal Muscular Atrophy to Accelerate Research and Improve Outcomes for Patients
|
Lochmüller, Hanns |
|
2018 |
5 |
2 |
p. 131-133 |
artikel |
13 |
Problems in Comparing Jitter Values Obtained with Voluntary Activation and Electrical Stimulation
|
Stålberg, Erik |
|
2018 |
5 |
2 |
p. 225-230 |
artikel |
14 |
Relationships between Lower Limb Muscle Strength Impairments and Physical Limitations in DM1
|
Petitclerc, Émilie |
|
2018 |
5 |
2 |
p. 215-224 |
artikel |
15 |
Serum Acetylcholine Receptor Antibodies Before the Clinical Onset of Myasthenia Gravis
|
Strijbos, Ellen |
|
2018 |
5 |
2 |
p. 261-264 |
artikel |
16 |
Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening
|
Glascock, Jacqueline |
|
2018 |
5 |
2 |
p. 145-158 |
artikel |